1d
MedPage Today on MSNPembrolizumab-Olaparib Boosts PFS in Non-BRCA Ovarian CancerA first-line regimen involving pembrolizumab (Keytruda) and olaparib (Lynparza) significantly reduced the risk of disease ...
Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic carcinoma.
TRIFOUR is Cantargia's first randomized, controlled study of nadunolimabFirst preliminary efficacy results expected mid-2025 LUND, SWEDEN / ACCESS Newswire / March 10, 2025 / Cantargia (Cantargia AB); ...
For nearly 20 years, mesothelioma treatment options were limited to a single regimen: pemetrexed with a platinum agent. Now, ...
Among patients with early-stage triple-negative breast cancer, a beneficial pathologic complete response rate was higher in ...
Discover a study where results suggest trends towards overall survival and progression-free survival improvements with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results